WAIVER AND TERMINATION AGREEMENTWaiver and Termination Agreement • September 8th, 2003 • Open Joint Stock Co Vimpel Communications • Radiotelephone communications • New York
This WAIVER AND TERMINATION AGREEMENT (this “Agreement”), dated as of the 28th day of August, 2003, by and among OPEN JOINT STOCK COMPANY “VIMPEL-COMMUNICATIONS”, an open joint stock company organized and existing under the laws of the Russian Federation (“VIP”), ECO TELECOM LIMITED, a company organized and existing under the laws of Gibraltar (“Eco Telecom”), TELENOR EAST INVEST AS, a company organized and existing under the laws of Norway (“Telenor”) and OPEN JOINT STOCK COMPANY “VIMPELCOM-REGION”, an open joint stock company organized and existing under the laws of the Russian Federation (“VIP-R”).
August 29, 2001 SCP Private Equity Partners II, L.P. Building 300 435 Devon Park Drive Wayne, PA 19087-1993 Attn: Wayne Weisman Re: Breakaway Solutions, Inc. ------------------------- Gentlemen and Ladies: By this Letter Agreement, ICG Holdings, Inc.,...Waiver and Termination Agreement • September 5th, 2001 • SCP Private Equity Partners Ii Lp • Services-business services, nec
WAIVER AND TERMINATION AGREEMENTWaiver and Termination Agreement • December 14th, 2007 • SOI Holdings, Inc. • Services-help supply services • New York
THIS WAIVER AND TERMINATION AGREEMENT (“Agreement”) is dated as of the 27th day of August, 2007, by and between Clarion Operating, LLC (“Clarion”) and SOI Holdings, Inc. (“SOI” and together with Clarion, the “Parties”).
WAIVER AND TERMINATION AGREEMENTWaiver and Termination Agreement • March 5th, 2009 • American Tower Corp /Ma/ • Communications services, nec • Massachusetts
This Waiver and Termination Agreement (this “Agreement”) is executed as of this day of March 2009 by and between American Tower Corporation, a Delaware corporation and its subsidiaries and affiliates (collectively the “Company”) and (“Employee,” and together with the Company, the “Parties,” and each, a “Party”).
WAIVER AND TERMINATION AGREEMENT DATED 8 NOVEMBER, 2002 (THE “EFFECTIVE DATE”)Waiver and Termination Agreement • March 31st, 2003 • Depomed Inc • Pharmaceutical preparations
Whereas, Elan Corporation, plc, an Irish public limited company (“Elan”), DepoMed, Inc., a California corporation (the “Company”), Elan Pharma International Limited, a private limited company incorporated under the laws of Ireland (“EPIL”), and DepoMed Development Ltd., a Bermuda exempted limited liability company (“Newco”), entered into a License Agreement, dated January 21, 2000 (the “Elan License Agreement”), which set forth the terms and conditions of a license from Elan to Newco of certain intellectual property of Elan.
EXHIBIT 10.24Waiver and Termination Agreement • March 31st, 1999 • Gerber Childrenswear Inc • Apparel & other finishd prods of fabrics & similar matl • New York
Waiver and Termination AgreementWaiver and Termination Agreement • August 5th, 2020 • Newell Brands Inc. • Plastics products, nec
By signature below, the undersigned “Executive” acknowledges and agrees with Newell Brands Inc. (the “Company”) that the Newell Brands Executive Severance Plan (the “Plan”), effective July 26, 2019, replaces and supersedes, and the Executive hereby waives, any rights to severance payments and other severance benefits under any employment security agreement (“ESA”) or other written agreement between Executive and the Company and/or any of its Affiliates in effect as of the effective date of Executive’s participation in the Plan (other than any provisions thereof that apply to Executive’s awards with respect to the securities of Newell that were granted prior to the effective date of Executive’s participation in the Plan); provided that, notwithstanding any other provision of the Plan, all of Executive’s awards with respect to the securities of the Company that are still outstanding upon the date of Executive’s termination of employment and that were granted prior to the date Executive s
WAIVER AND TERMINATION AGREEMENTWaiver and Termination Agreement • November 16th, 2018 • Fortress Biotech, Inc. • Pharmaceutical preparations • Delaware
THIS WAIVER AND TERMINATION AGREEMENT (as may be amended or modified from time to time, this “Agreement”) is entered into on November 12, 2018, by and among Fortress Biotech, Inc., a Delaware corporation (“Fortress”), Avenue Therapeutics, Inc., a Delaware corporation (the “Company”), and InvaGen Pharmaceuticals Inc., a New York corporation (“Buyer”).
